STATEMENT SHOWING THE PRICE FIXED/REVISED BY THE
NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 21st JANUARY, 2010
| Item No. | Company Name/Formulation Name/Composition | Pack Size | Existing Price (Rs.) |
Revised Price (Rs.) |
%AGE Increase/Decrease | Remarks |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
|
-- |
||||||
| (i) | Non-Ceiling Packs |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| A | IMPORTED CASES |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
||||
|
-- |
M/s. Pfizer Products India Pvt. Ltd. | (Sr. No. 1 to 3 For post – facto approval of the Authority) | ||||
|
-- |
-- |
-- |
||||
| 1 | Solu Medrol AOV 500 mg | 4 ml | 653.66 | 639.18 | -2.21 | NCP |
|
-- |
Each vial contains: | Vial |
-- |
-- |
||
|
-- |
Methyl Prednisolone Sodium |
-- |
-- |
-- |
-- |
|
|
-- |
Succinate – 500 mg |
-- |
-- |
-- |
||
|
-- |
Batch No. OA3XF / Qty. 18338 Vials |
-- |
-- |
-- |
||
|
-- |
Batch No. OA4PC / Qty. 22474 Vials |
-- |
-- |
-- |
||
|
-- |
Batch No. OA5FR / Qty. 23543 Vials |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
|||
| 2 | Medrol 4 mg | 10×10’s | 338.86 | 330.82 | -2.37 | NCP |
|
-- |
Each tablet contains: | Strip/Blister |
-- |
-- |
-- |
|
|
-- |
Methyl Prednisolone – 4 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Batch no. L558A / Qty. 34320 Strip |
-- |
-- |
-- |
||
|
-- |
Batch no. L352D, L557A & L559A / Qty. 69258 Strip |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 3 | Solu Medrol AOV 1000 mg | 8 ml | 1046.28 | 1023.25 | -2.20 | NCP |
|
-- |
Each Vial contains: | Vial |
-- |
-- |
-- |
|
|
-- |
Methyl Prednisolone Sodium |
-- |
-- |
-- |
-- |
|
|
-- |
Succinate – 1000 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Batch no. 0A4X0 / Total Qty. 33572 Vials |
-- |
-- |
-- |
||
|
-- |
Batch no. 0A5FX / Total Qty. 18000 Vials |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
|
-- |
M/s. Pfizer Products India Pvt. Ltd. |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 4 | Depo-Medrol 80 mg (40mg/ml) | 2 ml | 76.16 | 76.14 | -0.03 | NCP |
|
-- |
Each ml contains: | Vial |
-- |
-- |
-- |
|
|
-- |
Methyl Prednisolone Acetate – 80 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Batch no. S07849 / Qty. 228898 Vials |
-- |
-- |
-- |
||
|
-- |
Batch no. SO6935 / Qty.159910 Vials |
-- |
-- |
-- |
||
|
-- |
Batch no. SO8793 / Qty.184280 Vials |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 5 | Solu Medrol AOV 40 mg | 1 ml | 140.08 | 140.08 | 0.00 | NCP |
|
-- |
Each vial contains: | Vial |
-- |
-- |
||
|
-- |
Methyl Prednisolone Sodium Succinate – 40 mg |
-- |
-- |
-- |
||
|
-- |
Batch No. S08395 / Qty. 90378 Vials |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
|||
| 6 | Solu Medrol AOV 125 mg | 2 ml | 266.37 | 266.37 | 0.00 | NCP |
|
-- |
Each vial contains: | Vial |
-- |
-- |
||
|
-- |
Methyl Prednisolone Sodium Succinate – 125 mg |
-- |
-- |
-- |
||
|
-- |
Batch no. S08051 / Qty. 73395 Vials |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
|||
| 7 | Solu Medrol AOV 500 mg | 4 ml | 639.18 | 639.18 | 0.00 | NCP |
|
-- |
Each vial contains: | Vial |
-- |
-- |
||
|
-- |
Methyl Prednisolone Sodium |
-- |
-- |
-- |
||
|
-- |
Succinate – 500 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Batch no. OA5WK / Qty. 23496 Vials |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 8 | Solu Medrol AOV 1000 mg | 8 ml | 1023.25 | 1022.74 | -0.05 | NCP |
|
-- |
Each Vial contains: | Vial |
-- |
-- |
||
|
-- |
Methyl Prednisolone Sodium |
-- |
-- |
-- |
||
|
-- |
Succinate – 1000 mg |
-- |
-- |
-- |
||
|
-- |
Batch no. 0A6H5 / Qty. 27424 Vials |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
|||
| 9 | Medrol 4 mg | 10×10’s | 330.82 | 330.82 | 0.00 | NCP |
|
-- |
Each tablet contains: | Strip/Blister |
-- |
-- |
||
|
-- |
Methyl Prednisolone – 4 mg |
-- |
-- |
-- |
||
|
-- |
Batch no. M297A / Qty. 34800 |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
|||
| 10 | Depo-Medrol 40 mg | 1 ml | 57.78 | 57.78 | 0.00 | NCP |
|
-- |
Each vial contains: | Vial |
-- |
-- |
||
|
-- |
Methyl Prednisolone Acetate – 40 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Batch no. S10084 / Total Qty. 109757 Vials |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
|||
|
-- |
M/s. Novartis India Ltd. |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 11 | Vitalux Plus TR Tablets | 30 | 261.30 | 260.24 | -0.41 | NCP |
|
-- |
Each tablet contains: | Bottle |
-- |
-- |
-- |
|
|
-- |
Beta-Carotene (Provitamin A) – 10000 IU |
-- |
-- |
-- |
||
|
-- |
Vitamin C (Ascorbic Acid) – 300 mg |
-- |
-- |
-- |
||
|
-- |
Vitamin E(d-alpha tocopheryl acetate) – 100 IU |
-- |
-- |
-- |
||
|
-- |
Vitamin B2 (Riboflavin) – 20 mg |
-- |
-- |
-- |
||
|
-- |
Selenium (HVP* chelate) – 50 mcg |
-- |
-- |
-- |
||
|
-- |
Zinc (Gluconate) – 40 mg |
-- |
-- |
-- |
||
|
-- |
Copper (HVP* chelate) – 2 mg |
-- |
-- |
-- |
||
|
-- |
Lutein (supplying 176 mcg of Zeaxanthin) – 4mcg |
-- |
-- |
-- |
||
|
-- |
Batch no. 1694068, 1665235 / Qty. 13515 |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
||||
|
-- |
M/s Novo Nordisk India Pvt. Ltd. |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
|||
| 12 | Actrapid Flexpen | 5×3 ml | — | 1575.90 | — | NCP |
|
-- |
Each ml contains: |
-- |
-- |
-- |
-- |
|
|
-- |
Soluble Insulin injection |
-- |
-- |
-- |
||
|
-- |
Monocomponent human insulin, |
-- |
-- |
-- |
||
|
-- |
biosynthetic, (rDNA-origin), – 100 IU/ml |
-- |
-- |
-- |
||
|
-- |
in 3 ml precision dilivery deivce |
-- |
-- |
-- |
||
|
-- |
Batch No. XP52334 / Qty. 150 |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
|||
| 13 | Insulatard Flexpen | 5×3 ml | — | 1575.90 | — | NCP |
|
-- |
Each ml contains: |
-- |
-- |
-- |
-- |
|
|
-- |
Isophane Insulin injection |
-- |
-- |
-- |
||
|
-- |
Monocomponent human insulin, |
-- |
-- |
-- |
||
|
-- |
biosynthetic, (rDNA-origin), – 100 IU/ml |
-- |
-- |
-- |
||
|
-- |
in 3 ml precision dilivery deivce |
-- |
-- |
-- |
||
|
-- |
Batch No. XP52213 / Qty. 150 |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
|||
| 14 | Mixtard 30 Flexpen |  5×3 ml |
— | 1575.90 | — | NCP |
|
-- |
Each ml contains: |
-- |
-- |
-- |
||
|
-- |
Biphasic Isophane Insulin injection |
-- |
-- |
-- |
||
|
-- |
Monocomponent human insulin, |
-- |
-- |
-- |
||
|
-- |
biosynthetic, (rDNA-origin), |
-- |
-- |
-- |
||
|
-- |
(Mixture of soluble, neutral human insulin |
-- |
-- |
-- |
||
|
-- |
solution (30%) and Isophane insulin suspension |
-- |
-- |
-- |
||
|
-- |
(70%), 100 IU/ml in 3 ml precision delivery device |
-- |
-- |
-- |
||
|
-- |
Batch No. XP52434 / Qty. 150 |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
|||
|
-- |
M/s. Sanofi Aventis Pharma Ltd. |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 15 | Insuman 25/75 | 10 ml | 189.71 | 189.71 | 0.00 | NCP |
|
-- |
Each ml contains | Vial |
-- |
-- |
-- |
|
|
-- |
H-Insulin – 40 IU/ml |
-- |
-- |
-- |
||
|
-- |
(Recombinat DNA origin) |
-- |
-- |
-- |
-- |
|
|
-- |
Batch no. 40C094 / Qty. 63200 |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
|||
| 16 | Insuman Basal | 10 ml | 189.71 | 189.71 | 0.00 | NCP |
|
-- |
Each ml contains: | Vial |
-- |
-- |
-- |
|
|
-- |
H-Insulin – 40 IU/ml |
-- |
-- |
-- |
||
|
-- |
(Recombinat DNA origin) |
-- |
-- |
-- |
||
|
-- |
Batch no. 42C059 / Qty. 5600 |
-- |
-- |
-- |
-- |
|
|
-- |
Batch no. 41C059 / Qty. 11200 |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 17 | Insuman Rapid | 10 ml | 189.71 | 189.71 | 0.00 | NCP |
|
-- |
Each ml contains: | Vial |
-- |
-- |
-- |
|
|
-- |
H-Insulin – 40 IU/ml |
-- |
-- |
-- |
-- |
|
|
-- |
(Recombinat DNA origin) |
-- |
-- |
-- |
||
|
-- |
Batch no. 40C102 / Qty. 33600 |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
|||
|
-- |
M/s. Shreya Life sciences Pvt. Ltd. |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
||||
| 18 | Recosulin M30 100iu/ml | 3 ml | 220.01 | 214.80 | -2.37 | NCP |
|
-- |
(Recombinant Human Monocomponent Insulin ) | cartridge |
-- |
-- |
-- |
|
|
-- |
Each ml contains:- |
-- |
-- |
-- |
-- |
|
|
-- |
30/70 of Insulin Ph. Eur & |
-- |
-- |
-- |
-- |
|
|
-- |
Isophane Human Insulin 100iu |
-- |
-- |
-- |
||
|
-- |
M-cresol USP (as preservative) – 1.5mg |
-- |
-- |
-- |
||
|
-- |
Phenol Ph Eur (as preservative) – 0.65mg |
-- |
-- |
-- |
-- |
|
|
-- |
Excipients – QS |
-- |
-- |
-- |
-- |
|
|
-- |
Batch No. 61010709 / Qty. 30000 Cartridges Imported |
-- |
-- |
|||
|
-- |
Batch No. 61010809 / Qty. 24315 Cartridges Imported |
-- |
-- |
-- |
||
|
-- |
Batch No. 61010909 / Qty. 5685 Cartridges Imported |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
|||
| 19 | Recosulin M50 100iu/ml | 3 ml | 220.01 | 214.80 | -2.37 | NCP |
|
-- |
(Recombinant Human Monocomponent Insulin) | cartridge |
-- |
-- |
-- |
|
|
-- |
Each ml contains:- |
-- |
-- |
-- |
-- |
|
|
-- |
50/50 of Insulin Ph. Eur & |
-- |
-- |
-- |
||
|
-- |
Isophane Human Insulin 100iu |
-- |
-- |
-- |
||
|
-- |
M-cresol USP (as preservative) – 1.5mg |
-- |
-- |
-- |
-- |
|
|
-- |
Phenol Ph Eur (as preservative) – 0.65mg |
-- |
-- |
-- |
||
|
-- |
Excipients – QS |
-- |
-- |
-- |
||
|
-- |
Batch No. 63010909 / Qty. 5050 Cartridges Imported |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 20 | Recosulin R 100iu/ml | 3 ml | 197.23 | 214.80 | 8.91 | NCP |
|
-- |
(Recombinant Human Monocomponent Insulin) | cartridge |
-- |
-- |
||
|
-- |
Each ml contains:- |
-- |
-- |
-- |
-- |
|
|
-- |
Human Insulin Ph Eur – 100iu |
-- |
-- |
-- |
-- |
|
|
-- |
M-cresol USP (as preservative)- 3mg |
-- |
-- |
-- |
||
|
-- |
Excipients – QS |
-- |
-- |
-- |
||
|
-- |
Batch No. 57010709 / Qty. 3000 Cartridges Imported |
-- |
-- |
-- |
-- |
|
|
-- |
Batch No. 57010809 / Qty. 2500 Cartridges Imported |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| B | NEW CASES |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
M/s M. J. Biopharm Pvt Ltd. | |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 21 | Biosulin-R | 3ml |
— | 144.84 | — | NCP |
|
-- |
Insulin Injection Soluble (Neutral) 100IU | cartridge |
-- |
-- |
||
|
-- |
Each ml Contains: | in Blister |
-- |
-- |
||
|
-- |
Human Insulin – 100IU |
-- |
-- |
-- |
-- |
|
|
-- |
(Human Insulin rDNA Origin) |
-- |
-- |
-- |
||
|
-- |
M- Cresol – 0.25% w/v |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 22 | Biosulin -N (NPH) | 3ml | — | 146.74 | — | NCP |
|
-- |
Insulin Injection Isophane 100IU | cartridge |
-- |
-- |
||
|
-- |
Each ml Contains: | in Blister |
-- |
-- |
-- |
|
|
-- |
Human Insulin – 100IU | (with Glass Ball) |
-- |
-- |
||
|
-- |
(Human Insulin rDNA Origin) |
-- |
-- |
-- |
-- |
|
|
-- |
M- Cresol – 0.16% w/v |
-- |
-- |
-- |
||
|
-- |
Phenol IP 0.065% w/v |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 23 | Biosulin 30:70 | 3ml | — | 146.54 | — | NCP |
|
-- |
Insulin Injection, Biphasic Isophane IP 100ml | cartridge |
-- |
-- |
-- |
|
|
-- |
Each ml Contains: | in Blister |
-- |
-- |
||
|
-- |
Human Insulin – 100IU | (with Glass Ball) |
-- |
-- |
||
|
-- |
(Contain 30% Solube Insulin & 70% Isophane Insulin ) |
-- |
-- |
|||
|
-- |
Human Insulin rDNA Origin) |
-- |
-- |
-- |
||
|
-- |
M- Cresol – 0.16% w/v |
-- |
-- |
-- |
||
|
-- |
Phenol – 0.065% w/v |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 24 | Biosulin 50:50 | 3ml | — | 146.46 | — | NCP |
|
-- |
Insulin Injection, Biphasic Isophane 100IU/ml | cartridge |
-- |
-- |
||
|
-- |
Each ml Contains: | in Blister |
-- |
-- |
||
|
-- |
Human Insulin – 100IU | (with Glass Ball) |
-- |
-- |
||
|
-- |
(Contain 50% Solube Insulin & 50% Isophane Insuli |
-- |
-- |
-- |
||
|
-- |
Human Insulin rDNA Origin) |
-- |
-- |
-- |
||
|
-- |
M- Cresol – 0.16% w/v |
-- |
-- |
-- |
||
|
-- |
Phenol – 0.065% w/v |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 25 | Lupisulin -N | 3ml Cartridge |
— | 146.74 | — | NCP |
|
-- |
Insulin Injection Isophane 100IU | (with Glass Ball) |
-- |
-- |
||
|
-- |
Each ml Contains: |
-- |
-- |
-- |
||
|
-- |
Human Insulin – 100IU |
-- |
-- |
-- |
||
|
-- |
(Human Insulin rDNA Origin) |
-- |
-- |
-- |
||
|
-- |
M- Cresol – 0.16% w/v |
-- |
-- |
-- |
||
|
-- |
Phenol – 0.065% w/v |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 26 | Lupisulin M 50 | 3ml Cartridge | — | 146.46 | — | NCP |
|
-- |
Insulin Injection, Biphasic Isophane IP 100IU/ml | (with Glass Ball) |
-- |
-- |
||
|
-- |
Each ml Contains |
-- |
-- |
-- |
||
|
-- |
Human Insulin – 100IU |
-- |
-- |
-- |
||
|
-- |
(Contain 50% Solube Insulin & 50% Isophane Insulin) |
-- |
-- |
|||
|
-- |
Human Insulin rDNA Origin) |
-- |
-- |
-- |
||
|
-- |
M- Cresol – 0.16% w/v |
-- |
-- |
-- |
||
|
-- |
Phenol – 0.065% w/v |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 27 | Lupisulin -R | 3ml Cartridge | — | 144.84 | — | NCP |
|
-- |
Insulin Injection Solube (Neutral) 100IU |
-- |
-- |
-- |
||
|
-- |
3ml Cartridge |
-- |
-- |
-- |
-- |
|
|
-- |
Each ml Contains: |
-- |
-- |
-- |
||
|
-- |
Human Insulin – 100IU |
-- |
-- |
-- |
||
|
-- |
(Human Insulin rDNA Origin) |
-- |
-- |
-- |
||
|
-- |
M- Cresol USP 0.25% w/v |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 28 | Lupisulin M 30 | 3ml Cartridge | — | 146.54 | — | NCP |
|
-- |
Insulin Injection, Biphasic Isophane IP 100ml | (with Glass Ball) |
-- |
-- |
||
|
-- |
Each ml Contains: |
-- |
-- |
-- |
-- |
|
|
-- |
Human Insulin – 100IU |
-- |
-- |
-- |
||
|
-- |
(Contain 30% Solube Insulin & 70% Isophane Insulin ) |
-- |
-- |
|||
|
-- |
Human Insulin rDNA Origin) |
-- |
-- |
-- |
||
|
-- |
M- Cresol – 0.16% w/v |
-- |
-- |
-- |
||
|
-- |
Phenol – 0.065% w/v |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| C | REVISION CASES |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
|
-- |
M/s Torrent Pharmaceutical ltd. |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 29 | Human Actrapid 40 | 10 ml | 152.48 | 162.54 | 6.60 | NCP |
|
-- |
Soluble Insulin injection | Vial |
-- |
-- |
||
|
-- |
Human Actrapid |
-- |
-- |
-- |
||
|
-- |
Each ml Contains: |
-- |
-- |
-- |
||
|
-- |
Human Insulin – 40 IU |
-- |
-- |
-- |
||
|
-- |
Metacresol (as preservative) – 3 mg |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 30 | Human Mixtard (30 / 70) | 10 ml | 152.56 | 162.54 | 6.54 | NCP |
|
-- |
Biphasic Isophane Insulin Injection | Vial |
-- |
-- |
-- |
|
|
-- |
Human Mixtard |
-- |
-- |
-- |
-- |
|
|
-- |
Each ml Contains: |
-- |
-- |
-- |
-- |
|
|
-- |
Human Insulin – 40 IU |
-- |
-- |
-- |
-- |
|
|
-- |
(30% as Soluble Insulin and |
-- |
-- |
-- |
||
|
-- |
70% Isophane Insulin) |
-- |
-- |
-- |
-- |
|
|
-- |
Metacresol (as preservative) – 1.5 mg |
-- |
-- |
-- |
||
|
-- |
Phenol (as preservative) – 0.65 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Mono Component Human Insulin |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 31 | Human Mixtard (50 / 50) | 10 ml | 152.56 | 162.54 | 6.54 | NCP |
|
-- |
Biphasic Isophane Insulin Injection | Vial |
-- |
-- |
-- |
|
|
-- |
Human Mixtard |
-- |
-- |
-- |
-- |
|
|
-- |
Each ml Contains: |
-- |
-- |
-- |
||
|
-- |
Human Insulin – 40 IU |
-- |
-- |
-- |
-- |
|
|
-- |
(50% as Soluble Insulin and |
-- |
-- |
-- |
-- |
|
|
-- |
50% Isophane Insulin) |
-- |
-- |
-- |
-- |
|
|
-- |
Metacresol (as preservative) – 1.5 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Phenol (as preservative) – 0.65 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Mono Component Human Insulin |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 32 | Human Insulatard 40 IU/ML | 10 ml | 152.58 | 162.54 | 6.53 | NCP |
|
-- |
Isophane Insulin injection | Vial |
-- |
-- |
||
|
-- |
Human Insulatard |
-- |
-- |
-- |
-- |
|
|
-- |
Each ml Contains: |
-- |
-- |
-- |
||
|
-- |
Human Insulin – 40 IU |
-- |
-- |
-- |
||
|
-- |
Metacresol (as preservative) – 1.5 mg |
-- |
-- |
-- |
||
|
-- |
Phenol (as preservative) – 0.65 mg |
-- |
-- |
-- |
||
|
-- |
Mono component Human Insulin |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
|
-- |
M/s. Wockhardt Ltd. |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 33 | Spasmo Proxyvon | 8’s | 15.30 | 15.96 | 4.31 | NCP |
|
-- |
Each capsule contains: | Al/PVDC |
-- |
-- |
-- |
|
|
-- |
Dicyclomine HCL – 10 mg | Blister Foil |
-- |
-- |
-- |
|
|
-- |
Dextropropoxyphene Napsylate – 100 mg | With Hologram |
-- |
-- |
-- |
|
|
-- |
Acetaminophen – 400 mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 34 | Proxyvon Capsules | 8’s | 14.92 | 15.56 | 4.29 | NCP |
|
-- |
Each capsule contains: | Al/PVDC |
-- |
-- |
-- |
|
|
-- |
Dextropropoxyphene Napsylate – 100 mg | Blister Foil |
-- |
-- |
-- |
|
|
-- |
Acetaminophen – 400 mg | With Hologram |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| E | Complaint cases referred by Monitoring and Enforcement Division |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
-- |
|
|
-- |
M/s. Cipla Ltd. |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 35 | Theoped (Syrup) | 100ml Bottle | — | 9.51 | — | NCP |
|
-- |
Each 5ml contains | with M.Cup |
-- |
-- |
-- |
-- |
|
-- |
Theophylline (Anhydrous)-50mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| (ii) | Ceiling Packs |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| B | NEW CASES |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 36 | Chlorpromazine+ Trihexyphenidyl Tablets | 10’s | — | 10.82 | — | CP |
|
-- |
Each film coated tablet contains | Strip/Blister |
-- |
-- |
||
|
-- |
Chlorpromazine Hydrochloride – 200 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Trihexyphenidyl HCl – 2 mg |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 37 | Gentamycin+Hydrocortisone Acetate Eye Drops | 10 ml Vial | — | 15.00 | — | CP |
|
-- |
Each ml contains |
-- |
-- |
-- |
||
|
-- |
Gentamicine sulphate – 0.3% w/v |
-- |
-- |
-- |
-- |
|
|
-- |
eq. to Gentamicine base (3000 units/ml) |
-- |
-- |
-- |
-- |
|
|
-- |
Hydrocortisone Acetate – 1% w/v |
-- |
-- |
-- |
||
|
-- |
-- |
|
-- |
-- |
||
| 38 | Same Composition at Sl. No. 37 | 5 ml Vial | — | 9.96 | — | CP |
|
-- |
-- |
|
-- |
-- |
||
| 39 | Same Composition at Sl. No. 37 | 15 ml Vial | — | 19.32 | — | CP |
|
-- |
-- |
|
-- |
-- |
||
| 40 | Same Composition at Sl. No. 37 | 20 ml Vial | — | 24.24 | — | CP |
|
-- |
-- |
|
-- |
-- |
||
| 41 | Same Composition at Sl. No. 37 | 30 ml Vial | — | 32.50 | — | CP |
|
-- |
-- |
|
-- |
-- |
||
| 42 | Same Composition at Sl. No. 37 | 50 ml Vial | — | 49.66 | — | CP |
|
-- |
-- |
|
-- |
-- |
||
| 43 | Same Composition at Sl. No. 37 | 100 ml Vial | — | 91.36 | — | CP |
|
-- |
-- |
-- |
-- |
-- |
||
| 44 | Sulfsalazine Tablet | 10’s | — | 63.02 | — | CP |
|
-- |
Each enteric coated tablet contains | ST/BL |
-- |
-- |
-- |
|
|
-- |
Sulfsalazine – 1000 mg |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| C | REVISION CASES |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 45 | Ascorbic Acid + Sodium Ascobate Tablet | 10’s Al_Strip | 9.83 | 10.94 | 11.29 | CP |
|
-- |
Each chewable tablet contains | 0.04 MM |
-- |
-- |
||
|
-- |
Ascorbic Acid 200mg |
-- |
-- |
-- |
||
|
-- |
Sodium Ascobate 338mg |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
|||
| 46 | Chlorpromazine+Trifluoperazine+ | 10’s | 5.20 | 6.94 | 33.46 | CP |
|
-- |
Trihexyphenidyl Tablet | Strip/Blister |
-- |
-- |
-- |
|
|
-- |
Each film coated tablet contains |
-- |
-- |
-- |
||
|
-- |
Chlorpromazine Hydrochloride – 100 mg |
-- |
-- |
-- |
||
|
-- |
Trifluoperazine HCl – 5 mg |
-- |
-- |
-- |
||
|
-- |
Trihexyphenidyl HCl – 2 mg |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 47 | Prednisolone Tablet | 10’s Al_Blister | 2.72 | 2.72 | 0.00 | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 2.5mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 48 | Prednisolone Tablet | 10’s Al_Strip | — | 2.94 | — | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 2.5mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 49 | Prednisolone Tablet | 10’s Al_Blister | 3.86 | 3.88 | 0.52 | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 5mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 50 | Prednisolone Tablet | 10’s Al_Strip | — | 4.10 | — | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 5mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 51 | Prednisolone Tablet | 10’s Al_Blister | 6.48 | 6.50 | 0.31 | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 10mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 52 | Prednisolone Tablet | 10’s Al_Strip | — | 6.72 | — | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 10mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 53 | Prednisolone Tablet | 10’s Al_Blister | 11.96 | 12.00 | 0.33 | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 20mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 54 | Prednisolone Tablet | 10’s Al_Strip | — | 12.26 | — | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 20mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 55 | Prednisolone Tablet | 10’s Al_Blister | 17.24 | 17.28 | 0.23 | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 30mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 56 | Prednisolone Tablet | 10’s Al_Strip | — | 17.54 | — | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 30mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 57 | Prednisolone Tablet | 10’s Al_Blister | 22.36 | 22.42 | 0.27 | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 40mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 58 | Prednisolone Tablet | 10’s Al_Strip | — | 22.68 | — | CP |
|
-- |
Each dispersible tablet contains |
-- |
-- |
-- |
-- |
|
|
-- |
Prednisolone – 40mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 59 | Naproxen Sodium Tablet | 10’s Al/PVC- | 11.48 | 11.68 | 1.74 | CP |
|
-- |
Each tablet contains | PVDC Blister |
-- |
-- |
-- |
|
|
-- |
Naproxen Sodium – 275 mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 60 | Sulfsalazine Tablet | 10’s | 34.96 | 32.90 | -5.89 | CP |
|
-- |
Each enteric coated tablet contains | Strip/Blister |
-- |
-- |
-- |
|
|
-- |
Sulfsalazine – 500 mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| D. | Suo- Moto Exercise based on Dextropropoxyphene Hcl |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 61 | Dextropropoxyphene+ | 10’s | 8.88 | 8.80 | -0.90 | CP |
|
-- |
Paracetamol and Others, Tablets | Strip/Blister |
-- |
-- |
-- |
|
|
-- |
Each Tablet contains : |
-- |
-- |
-- |
-- |
|
|
-- |
Dextropropoxyphene HCl -65 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Paracetamol – 650 mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 62 | Dextropropoxyphene+ | 10’s | 10.98 | 10.00 | -8.93 | CP |
|
-- |
Paracetamol/Acetaminophen+ | Strip/Blister |
-- |
-- |
-- |
|
|
-- |
Dicyclomine and Others, Capsule |
-- |
-- |
-- |
-- |
|
|
-- |
Each capsule contains |
-- |
-- |
-- |
-- |
|
|
-- |
Dextropropoxyphene Hcl -65 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Dicyclomine – 10 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Acetaminophen – 400 mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 63 | Dextropropoxyphene Hcl Capsule | 10’s | 8.58 | 8.18 | -4.66 | CP |
|
-- |
Each Capsule contains | Strip/Blister |
-- |
-- |
-- |
|
|
-- |
Dextropropoxyphene Hcl -65 mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 64 | Dextropropoxyphene Hcl Capsule | 100’s | 82.34 | 77.62 | -5.73 | CP |
|
-- |
Each Capsule contains | Bottle |
-- |
-- |
-- |
|
|
-- |
Dextropropoxyphene Hcl -65 mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 65 | Dextropropoxyphene Hcl Capsule | 100’s | 58.64 | 58.64 | 0.00 | CP |
|
-- |
Each Capsule contains | Bottle |
-- |
-- |
-- |
|
|
-- |
Dextropropoxyphene Hcl -32 mg |
-- |
-- |
-- |
-- |
|
|
-- |
Paracetamol – 350 mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| E | Complaint cases referred by Monitoring and Enforcement Division |
-- |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 66 | Levosalbutamol + Ipratropium Bromide Inhaler | 200 MT | — | 82.42 | — | CP |
|
-- |
Each meter dose / actuation delivers contains | Doses |
-- |
-- |
-- |
|
|
-- |
Levosalbutamol Sulphate |
-- |
-- |
-- |
-- |
|
|
-- |
eq. to Levosalbutamol-50mcg |
-- |
-- |
-- |
-- |
|
|
-- |
Ipratropium Bromide-20mcg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 67 | Levosalbutamol Inhaler | 250 MT | — | 74.13 | — | CP |
|
-- |
Each meter dose / actuation delivers contains | Doses |
-- |
-- |
-- |
|
|
-- |
Levosalbutamol Sulphate |
-- |
-- |
-- |
-- |
|
|
-- |
eq. to Levosalbutamol-50mcg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 68 | Erythromycin Estolate Tablet | 10’s | — | 18.14 | — | CP |
|
-- |
Each tablet contains | Strip/Blister |
-- |
-- |
-- |
|
|
-- |
Erythromycin Estolate eq. to |
-- |
-- |
-- |
-- |
|
|
-- |
Erythromycin Base -250mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 69 | Erythromycin Estolate Tablet | 10’s | — | 34.92 | — | CP |
|
-- |
Each tablet contains | Strip/Blister |
-- |
-- |
-- |
|
|
-- |
Erythromycin Estolate eq. to |
-- |
-- |
-- |
-- |
|
|
-- |
Erythromycin Base -500mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 70 | Erythromycin Estolate Tablet | 10’s | — | 7.94 | — | CP |
|
-- |
Each uncoated tablet contains | Strip/Blister |
-- |
-- |
-- |
|
|
-- |
Erythromycin Estolate eq. to |
-- |
-- |
-- |
-- |
|
|
-- |
Erythromycin Base -100mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 71 | Erythromycin Estolate Tablet | 10’s | — | 9.60 | — | CP |
|
-- |
Each uncoated tablet contains | Strip/Blister |
-- |
-- |
-- |
|
|
-- |
Erythromycin Estolate eq. to |
-- |
-- |
-- |
-- |
|
|
-- |
Erythromycin Base -125mg |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 72 | Dexamethasone+Ofloxacin+ | 10ml Vial | — | 10.24 | — | CP |
|
-- |
Hydroxypropyl Methyl Cellulose+ | with Carton |
-- |
-- |
||
|
-- |
Benzalkonium Chloride Eye/Ear Drops |
-- |
-- |
-- |
||
|
-- |
Each ml contains |
-- |
-- |
-- |
-- |
|
|
-- |
Dexamethasone Sodium Phosphate-0.05% w/v |
-- |
-- |
-- |
-- |
|
|
-- |
Ofloxacin – 0.3% w/v |
-- |
-- |
-- |
-- |
|
|
-- |
Hydroxypropyl Methyl Cellulose-0.25% w/v |
-- |
-- |
-- |
-- |
|
|
-- |
Benzalkonium Chloride Solution-0.02% w/v |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 73 | Same composition at Sl. No. 72 | 5ml Vial | — | 8.20 | — | CP |
|
-- |
-- |
with Carton |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 74 | Same composition at Sl. No. 72 | 15ml Vial | — | 11.54 | — | CP |
|
-- |
-- |
with Carton |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 75 | Same composition at Sl. No. 72 | 20ml Vial | — | 13.48 | — | CP |
|
-- |
-- |
with Carton |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 76 | Same composition at Sl. No. 72 | 30ml Vial | — | 15.72 | — | CP |
|
-- |
-- |
with Carton |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 77 | Same composition at Sl. No. 72 | 50ml Vial | — | 21.06 | — | CP |
|
-- |
-- |
with Carton |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 78 | Same composition at Sl. No. 72 | 100ml Vial | — | 34.04 | — | CP |
|
-- |
-- |
with Carton |
-- |
-- |
||
|
-- |
-- |
-- |
-- |
-- |
||
| 79 | Dexamethasone +Chlorampenicol + | 10ml Vial | — | 11.26 | — | CP |
|
-- |
Boric Acid+Phenylmercuric Nitrate Eye/Ear Drops | with Dropper |
-- |
-- |
||
|
-- |
Each ml contains | & Carton |
-- |
-- |
-- |
|
|
-- |
Dexamethasone Sodium Posphate-0.1% w/v |
-- |
-- |
-- |
-- |
|
|
-- |
Chlorampenicol-1% w/v |
-- |
-- |
-- |
-- |
|
|
-- |
Boric Acid -1.5% w/v |
-- |
-- |
-- |
-- |
|
|
-- |
(as Buffering agent) |
-- |
-- |
-- |
-- |
|
|
-- |
Phenylmercuric Nitrate-0.001% w/v (as prservative) |
-- |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
||
| 80 | Same composition at Sl. No. 79 | 5ml Vial | — | 8.72 | — | CP |
|
-- |
-- |
with Dropper |
-- |
-- |
||
|
-- |
-- |
& Carton |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 81 | Same composition at Sl. No. 79 | 15ml Vial | — | 13.08 | — | CP |
|
-- |
-- |
with Dropper |
-- |
-- |
||
|
-- |
-- |
& Carton |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 82 | Same composition at Sl. No. 79 | 20ml Vial | — | 15.52 | — | CP |
|
-- |
-- |
with Dropper |
-- |
-- |
||
|
-- |
-- |
& Carton |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 83 | Same composition at Sl. No. 79 | 30ml Vial | — | 18.78 | — | CP |
|
-- |
-- |
with Dropper |
-- |
-- |
||
|
-- |
-- |
& Carton |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 84 | Same composition at Sl. No. 79 | 50ml Vial | — | 26.16 | — | CP |
|
-- |
-- |
with Dropper |
-- |
-- |
||
|
-- |
-- |
& Carton |
-- |
-- |
-- |
|
|
-- |
-- |
-- |
-- |
-- |
-- |
|
| 85 | Same composition at Sl. No. 79 | 100ml Vial | — | 44.24 | — | CP |
|
-- |
-- |
with Dropper |
-- |
-- |
||
|
-- |
-- |
& Carton |
-- |
-- |
-- |
|
Last Page Updated: 03-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)